Back
Koppers Holdings 10K Form
Buy
74
KOP
Koppers Holdings
Last Price:
43.26
Seasonality Move:
1.11%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-03 | 10Q | KOP/Koppers Holdings Quarterly |
2023-08-03 | 10Q | KOP/Koppers Holdings Quarterly |
2023-05-05 | 10Q | KOP/Koppers Holdings Quarterly |
2022-11-04 | 10Q | KOP/Koppers Holdings Quarterly |
2022-08-04 | 10Q | KOP/Koppers Holdings Quarterly |
2022-05-06 | 10Q | KOP/Koppers Holdings Quarterly |
Receive KOP News And Ratings
See the #1 stock for the next 7 days that we like better than KOP
KOP Financial Statistics
Sales & Book Value
Annual Sales: | $1.98B |
---|---|
Cash Flow: | $52.9M |
Price / Cash Flow: | 0 |
Annual Sales: | $22.67 |
Price / Book: | 1.91 |
Profitability
EPS (TTM): | 4.21000 |
---|---|
Net Income (TTM): | $90.1M |
Gross Margin: | $344.6M |
Return on Equity: | 21.22% |
Return on Assets: | 5.13% |
Koppers Holdings Earnings Forecast
Key Koppers Holdings Financial Ratios
- The Gross Profit Margin over the past 22 years for KOP is 17.40%.
- The Selling, General & Administrative Expenses for KOP have been equal to 7.74% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 70.66% of Operating Income.
- The Net Earning history of KOP is 3.20% of Total Revenues.
- Per Share Earnings over the last 22 years have been positive in 10 years.
Koppers Holdings Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Specialty Chemicals |
Sector: | Basic Materials |
Current Symbol: | KOP |
CUSIP: | 50060P |
Website: | koppers.com |
Debt
Debt-to-Equity Ratio: | 1.83 |
---|---|
Current Ratio: | 2.24 |
Quick Ratio: | 0.94 |
Price-to-Earnings
Trailing P/E Ratio: | 14.5 |
---|---|
Forward P/E Ratio: | 9.19 |
KOP Technical Analysis vs Fundamental Analysis
Buy
74
Koppers Holdings (KOP)
is a Buy
Is Koppers Holdings a Buy or a Sell?
-
Koppers Holdings stock is rated a Buy
The current Koppers Holdings [KOP] share price is $43.20. The Score for KOP is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.